{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:03Z","timestamp":1793830923125,"version":"4.6.1"},"reference-count":110,"publisher":"European Respiratory Society (ERS)","issue":"180","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Bronchiectasis is a chronic respiratory disease characterised by irreversible bronchial dilatation, persistent airway inflammation and recurrent infections. Symptoms, particularly cough, sputum production and dyspnoea, are the most immediate and patient-relevant expression of the disease, linking clinical presentation, airway biology and outcomes. While asthma and COPD management algorithms already integrate symptom burden into therapeutic decision-making, bronchiectasis care has historically relied on exacerbation history to guide preventive interventions. Over the past decade, an expanding body of evidence has demonstrated that daily symptoms mirror current infection and inflammation, profoundly impact quality of life, and predict future exacerbations. Comparative analyses across chronic lung diseases further highlight the central role of symptom monitoring in defining disease activity and risk. The updated European Respiratory Society guidelines translate this evidence into clinical practice, marking a paradigm shift from an exacerbation-driven to a symptom-centred and treatable-traits model. This review synthesises clinical, biological and therapeutic insights linking symptoms to bronchiectasis pathophysiology, disease activity and treatment response. We discuss how airway clearance, mucoactive therapy, antibiotics, pulmonary rehabilitation and targeted anti-inflammatory strategies, including dipeptidyl peptidase-1 inhibition, can address specific symptom profiles. We also mention the role of comorbidities and psychosocial management, establishing symptoms as the cornerstone of a holistic, multidimensional care approach. Recognising symptoms as both biomarkers of activity and therapeutic targets represents a major step toward precision medicine in bronchiectasis, aligning clinical management with patient experience and the biological drivers of disease.<\/jats:p>","DOI":"10.1183\/16000617.0085-2026","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:30:26Z","timestamp":1782289826000},"page":"260085","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The importance of symptoms in bronchiectasis"],"prefix":"10.1183","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3544-0361","authenticated-orcid":false,"given":"Alessandro","family":"De Angelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Marrades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Faner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Iorfida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-4531","authenticated-orcid":false,"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026062401301009000_35.180.260085.1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2024"},{"key":"2026062401301009000_35.180.260085.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202310-1729OC"},{"key":"2026062401301009000_35.180.260085.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00777-2021"},{"key":"2026062401301009000_35.180.260085.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01899-2015"},{"key":"2026062401301009000_35.180.260085.6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0049-2024"},{"key":"2026062401301009000_35.180.260085.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01888-2015"},{"key":"2026062401301009000_35.180.260085.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000862"},{"key":"2026062401301009000_35.180.260085.9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0085-2024"},{"key":"2026062401301009000_35.180.260085.10","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0638-0"},{"key":"2026062401301009000_35.180.260085.11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global strategy for prevention, diagnosis and management of COPD: 2024 report. Date last updated: 2024. Date last accessed: January 2026. https:\/\/goldcopd.org\/2024-gold-report\/"},{"key":"2026062401301009000_35.180.260085.12","unstructured":"Global Initiative for Asthma . 2023 GINA report, global strategy for asthma management and prevention . Date last updated: 10 July 2023. Date last accessed: January 2026. https:\/\/ginasthma.org\/2023-gina-main-report\/"},{"key":"2026062401301009000_35.180.260085.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2026062401301009000_35.180.260085.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201910-1972OC"},{"key":"2026062401301009000_35.180.260085.15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-2600(25)00160-2","article-title":"Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study","volume":"13","author":"Sibila","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01126-2025"},{"key":"2026062401301009000_35.180.260085.17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2013a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"2026062401301009000_35.180.260085.18","doi-asserted-by":"crossref","first-page":"20210026","DOI":"10.1259\/bjro.20210026","article-title":"Imaging in non-cystic fibrosis bronchiectasis and current limitations","volume":"3","author":"Ledda","year":"2021","journal-title":"BJROpen"},{"key":"2026062401301009000_35.180.260085.19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1183\/20734735.0009-2019","article-title":"Diagnostic imaging in adult non-cystic fibrosis bronchiectasis","volume":"15","author":"Juliusson","year":"2019","journal-title":"Breathe (Sheff)"},{"key":"2026062401301009000_35.180.260085.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9700-3"},{"key":"2026062401301009000_35.180.260085.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01554-2023"},{"key":"2026062401301009000_35.180.260085.22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"2026062401301009000_35.180.260085.24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/resp.12219","article-title":"The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case\u2013control analysis","volume":"19","author":"Goeminne","year":"2014","journal-title":"Respirology"},{"key":"2026062401301009000_35.180.260085.25","first-page":"145","article-title":"The clinical features of bronchiectasis associated with alpha-1 antitrypsin deficiency, common variable immunodeficiency and primary ciliary dyskinesia-Results from the US bronchiectasis research registry","volume":"6","author":"Eden","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026062401301009000_35.180.260085.26","doi-asserted-by":"crossref","first-page":"14799731221098714","DOI":"10.1177\/14799731221098714","article-title":"Characterisation of the post-tuberculous phenotype of bronchiectasis: a real-world observational study","volume":"19","author":"Fong","year":"2022","journal-title":"Chron Respir Dis"},{"key":"2026062401301009000_35.180.260085.27","doi-asserted-by":"crossref","first-page":"e0177931","DOI":"10.1371\/journal.pone.0177931","article-title":"Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish bronchiectasis historical registry","volume":"12","author":"De la Rosa","year":"2017","journal-title":"PLoS One"},{"key":"2026062401301009000_35.180.260085.28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12890-021-01762-6","article-title":"Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study","volume":"21","author":"Lim","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026062401301009000_35.180.260085.29","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.21037\/jtd-22-1541","article-title":"Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea","volume":"15","author":"Seo","year":"2023","journal-title":"J Thorac Dis"},{"key":"2026062401301009000_35.180.260085.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2026062401301009000_35.180.260085.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2202OC"},{"key":"2026062401301009000_35.180.260085.32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2025.PA765"},{"key":"2026062401301009000_35.180.260085.33","doi-asserted-by":"crossref","unstructured":"Choi H , Chalmers JD . Bronchiectasis: from orphan disease to precision medicine. In: Wagner TOF , Humbert M , Wijsenbeek M , et al., eds. Rare Diseases of the Respiratory System (ERS Monograph). Sheffield, European Respiratory Society, 2023; pp. 150\u2013164. doi:10.1183\/2312508X.10018122","DOI":"10.1183\/2312508X.10018122"},{"key":"2026062401301009000_35.180.260085.34","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.06.41"},{"key":"2026062401301009000_35.180.260085.35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12890-024-03402-1","article-title":"Risk factors for readmission within one year after acute exacerbations of bronchiectasis in a Chinese tertiary hospital: a retrospective cohort study","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Pulm Med"},{"key":"2026062401301009000_35.180.260085.36","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00048-2025"},{"key":"2026062401301009000_35.180.260085.37","doi-asserted-by":"publisher","DOI":"10.1164\/RCCM.202108-1819PP\/SUPPL_FILE\/DISCLOSURES.PDF"},{"key":"2026062401301009000_35.180.260085.38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccm.2020.06.005","article-title":"Assessing symptom burden","volume":"41","author":"Vogelmeier","year":"2020","journal-title":"Clin Chest Med"},{"key":"2026062401301009000_35.180.260085.39","doi-asserted-by":"crossref","first-page":"100306","DOI":"10.1016\/j.opresp.2024.100306","article-title":"Biologics in COPD","volume":"6","author":"Kersul","year":"2024","journal-title":"Open Respir Arch"},{"key":"2026062401301009000_35.180.260085.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608969"},{"key":"2026062401301009000_35.180.260085.41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00328-2018"},{"key":"2026062401301009000_35.180.260085.42","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0548-3"},{"key":"2026062401301009000_35.180.260085.43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4168\/aair.2023.15.1.83","article-title":"Impacts of asthma in patients with bronchiectasis: findings from the KMBARC registry","volume":"15","author":"Moon","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"key":"2026062401301009000_35.180.260085.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.01.027"},{"key":"2026062401301009000_35.180.260085.45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1164\/rccm.202309-1614OC","article-title":"The association between bronchiectasis and chronic obstructive pulmonary disease: data from the European Bronchiectasis Registry (EMBARC)","volume":"210","author":"Polverino","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026062401301009000_35.180.260085.46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01269-2018"},{"key":"2026062401301009000_35.180.260085.47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01359-2015"},{"key":"2026062401301009000_35.180.260085.48","doi-asserted-by":"crossref","first-page":"17534666251390086","DOI":"10.1177\/17534666251390086","article-title":"Screening and impact of comorbidities in bronchiectasis: a forward-looking perspective","volume":"19","author":"De Angelis","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"2026062401301009000_35.180.260085.49","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00248-2024"},{"key":"2026062401301009000_35.180.260085.50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2213-2600(24)00364-3","article-title":"Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study","volume":"13","author":"Xu","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5578\/tt.69348","article-title":"Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis","volume":"68","author":"Bekir","year":"2020","journal-title":"Tuberk Toraks"},{"key":"2026062401301009000_35.180.260085.52","doi-asserted-by":"crossref","first-page":"20886","DOI":"10.1038\/s41598-023-48276-1","article-title":"The prevalence of anxiety and depression in bronchiectasis patients and their association with disease severity: a cross-sectional study","volume":"13","author":"Al Oweidat","year":"2023","journal-title":"Sci Rep"},{"key":"2026062401301009000_35.180.260085.53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5606\/tgkdc.dergisi.2021.20389","article-title":"Anxiety and depression as possible criteria in the treatment of bronchiectasis","volume":"29","author":"Keskin","year":"2021","journal-title":"Turkish J Thorac Cardiovasc Surg"},{"key":"2026062401301009000_35.180.260085.54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11136-012-0188-5","article-title":"Depression and anxiety symptoms in bronchiectasis: Associations with health-related quality of life","volume":"22","author":"Olveira","year":"2013","journal-title":"Qual Life Res"},{"key":"2026062401301009000_35.180.260085.55","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.2147\/NDT.S121147","article-title":"Factors related to depression and anxiety in adults with bronchiectasis","volume":"12","author":"\u00d6zg\u00fcn Niksarlioglu","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026062401301009000_35.180.260085.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00232-2016"},{"key":"2026062401301009000_35.180.260085.57","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-79"},{"key":"2026062401301009000_35.180.260085.58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01532-2016"},{"key":"2026062401301009000_35.180.260085.59","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205918"},{"key":"2026062401301009000_35.180.260085.60","doi-asserted-by":"crossref","first-page":"2100025","DOI":"10.1183\/13993003.00025-2021","article-title":"Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis","volume":"58","author":"McLeese","year":"2021","journal-title":"Eur Respir J"},{"key":"2026062401301009000_35.180.260085.61","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.chest.2019.10.030","article-title":"Validation of the COPD assessment test (CAT) as an outcome measure in bronchiectasis","volume":"157","author":"Finch","year":"2020","journal-title":"Chest"},{"key":"2026062401301009000_35.180.260085.62","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chest.2019.08.1916","article-title":"COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study","volume":"157","author":"De la Rosa Carrillo","year":"2020","journal-title":"Chest"},{"key":"2026062401301009000_35.180.260085.63","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01359-2024"},{"key":"2026062401301009000_35.180.260085.64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-019-1272-y","article-title":"Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)","volume":"21","author":"Artaraz","year":"2020","journal-title":"Respir Res"},{"key":"2026062401301009000_35.180.260085.65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4046\/trd.2024.0120","article-title":"Disease severity and activity in bronchiectasis: a paradigm shift in bronchiectasis management","volume":"88","author":"Im","year":"2025","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2026062401301009000_35.180.260085.66","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2026062401301009000_35.180.260085.67","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00026313"},{"key":"2026062401301009000_35.180.260085.68","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30320-4"},{"key":"2026062401301009000_35.180.260085.69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1513\/AnnalsATS.202302-133OC","article-title":"Quality-of-life bronchiectasis respiratory symptom scale predicts the risk of exacerbations in adults with bronchiectasis a prospective observational study","volume":"21","author":"Gao","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026062401301009000_35.180.260085.70","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.00163208","article-title":"Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2008","journal-title":"Eur Respir J"},{"key":"2026062401301009000_35.180.260085.71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/atm-22-3437","article-title":"Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention","volume":"11","author":"Choi","year":"2023","journal-title":"Ann Transl Med"},{"key":"2026062401301009000_35.180.260085.72","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00962-2024"},{"key":"2026062401301009000_35.180.260085.73","doi-asserted-by":"crossref","first-page":"0111-2024","DOI":"10.1183\/23120541.01111-2024","article-title":"Importance of sputum and computed tomography assessments of airway neutrophil inflammation and mucus plugging in bronchiectasis management","volume":"11","author":"Tanabe","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026062401301009000_35.180.260085.74","doi-asserted-by":"crossref","first-page":"00279-2024","DOI":"10.1183\/23120541.00279-2024","article-title":"Mucus plugging, disease severity and sputum myeloperoxidase concentration in bronchiectasis","volume":"11","author":"Kim","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026062401301009000_35.180.260085.75","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.2065"},{"key":"2026062401301009000_35.180.260085.76","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2248oc"},{"key":"2026062401301009000_35.180.260085.77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.arbres.2024.07.017","article-title":"Mucus plugs as precursors to exacerbation and lung function decline in COPD patients","volume":"61","author":"Jin","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"2026062401301009000_35.180.260085.78","first-page":"9874068","article-title":"Is there a correlation between new scoring systems and systemic inflammation in stable bronchiectasis?","volume":"2017","author":"Coban","year":"2017","journal-title":"Can Respir J"},{"key":"2026062401301009000_35.180.260085.79","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00285-2021"},{"key":"2026062401301009000_35.180.260085.80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbr.2019.12.022","article-title":"C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON)","volume":"57","author":"Posadas","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2026062401301009000_35.180.260085.81","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0691-x"},{"key":"2026062401301009000_35.180.260085.82","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0179-2024"},{"key":"2026062401301009000_35.180.260085.83","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.84","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/642503"},{"key":"2026062401301009000_35.180.260085.85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arbres.2022.09.004","article-title":"Pathophysiology of chronic bronchial infection in bronchiectasis","volume":"59","author":"Solarat","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"2026062401301009000_35.180.260085.86","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1651OC"},{"key":"2026062401301009000_35.180.260085.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.07.007"},{"key":"2026062401301009000_35.180.260085.88","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-2600(24)00225-X","article-title":"Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months","volume":"12","author":"Haworth","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12931-022-02243-y","article-title":"Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis","volume":"23","author":"Terpstra","year":"2022","journal-title":"Respir Res"},{"key":"2026062401301009000_35.180.260085.90","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/biomedicines9070772","article-title":"T2-high endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"key":"2026062401301009000_35.180.260085.91","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1889OC"},{"key":"2026062401301009000_35.180.260085.92","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids","volume":"164","author":"Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Chest"},{"key":"2026062401301009000_35.180.260085.93","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.21037\/jtd-2024-2106","article-title":"Addressing treatable traits in bronchiectasis through non-pharmacological therapies: a narrative review","volume":"17","author":"Lee","year":"2025","journal-title":"J Thorac Dis"},{"key":"2026062401301009000_35.180.260085.94","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31767-7"},{"key":"2026062401301009000_35.180.260085.95","first-page":"15","article-title":"Airway clearance techniques in bronchiectasis","volume":"8","author":"Basavaraj","year":"2025","journal-title":"J Precis Respir Med"},{"key":"2026062401301009000_35.180.260085.96","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","article-title":"Hypertonic saline or carbocisteine in bronchiectasis","volume":"393","author":"Bradley","year":"2025","journal-title":"N Engl J Med"},{"key":"2026062401301009000_35.180.260085.97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.arbres.2025.02.015","article-title":"Effect of N-acetylcysteine on nronchiectasis in a real-life study. Data From the Spanish RIBRON Registry","volume":"61","author":"Oscullo","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"2026062401301009000_35.180.260085.98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00408-022-00540-3","article-title":"Effects of pulmonary rehabilitation on systemic inflammation and exercise capacity in bronchiectasis: a randomized controlled trial","volume":"200","author":"Ara\u00fajo","year":"2022","journal-title":"Lung"},{"key":"2026062401301009000_35.180.260085.99","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"key":"2026062401301009000_35.180.260085.101","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.102","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chest.2023.05.016","article-title":"Eosinophils in bronchiectasis","volume":"164","author":"Pollock","year":"2023","journal-title":"Chest"},{"key":"2026062401301009000_35.180.260085.103","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221825"},{"key":"2026062401301009000_35.180.260085.104","doi-asserted-by":"crossref","first-page":"2501309","DOI":"10.1183\/13993003.01309-2025","article-title":"Emerging therapies in bronchiectasis","volume":"66","author":"Sibila","year":"2025","journal-title":"Eur Respir J"},{"key":"2026062401301009000_35.180.260085.105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021713"},{"key":"2026062401301009000_35.180.260085.106","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl J Med"},{"key":"2026062401301009000_35.180.260085.107","doi-asserted-by":"crossref","first-page":"2401551","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF\u00ae, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2024","journal-title":"Eur Respir J"},{"key":"2026062401301009000_35.180.260085.108","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026062401301009000_35.180.260085.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.06.031"},{"key":"2026062401301009000_35.180.260085.110","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01087-2024"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0085-2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:30:45Z","timestamp":1782289845000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0085-2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":110,"journal-issue":{"issue":"180","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1183\/16000617.0085-2026"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0085-2026","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}